Business Description
AEON Biopharma Inc
NAICS : 325412
SIC : 2834
ISIN : US00791X1000
Share Class Description:
AEON: Ordinary Shares - Class ADescription
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.03 | |||||
| Equity-to-Asset | -8.01 | |||||
| Debt-to-Equity | -0.51 | |||||
| Debt-to-EBITDA | -0.75 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Book Growth Rate | 33.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 28.79 | |||||
| 9-Day RSI | 24.81 | |||||
| 14-Day RSI | 28.48 | |||||
| 6-1 Month Momentum % | -34.67 | |||||
| 12-1 Month Momentum % | -82.25 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.22 | |||||
| Quick Ratio | 0.22 | |||||
| Cash Ratio | 0.05 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -35.9 | |||||
| Shareholder Yield % | 260.95 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | Neg. Equity | |||||
| ROA % | 536.11 | |||||
| ROIC % | -735.14 | |||||
| ROC (Joel Greenblatt) % | -2185.97 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 0.67 | |||||
| Forward PE Ratio | 0.68 | |||||
| EV-to-EBIT | -1.7 | |||||
| EV-to-Forward-EBIT | -3.26 | |||||
| EV-to-EBITDA | -1.71 | |||||
| EV-to-FCF | -1.92 | |||||
| Earnings Yield (Greenblatt) % | -58.82 | |||||
| FCF Yield % | -90.48 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with AMEX:AEON
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
AEON Biopharma Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | 0.81 | ||
| Beta | 0 | ||
| Volatility % | 157.1 | ||
| 14-Day RSI | 28.48 | ||
| 14-Day ATR ($) | 0.064302 | ||
| 20-Day SMA ($) | 0.67715 | ||
| 12-1 Month Momentum % | -82.25 | ||
| 52-Week Range ($) | 0.5206 - 17.17 | ||
| Shares Outstanding (Mil) | 39.97 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
AEON Biopharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
AEON Biopharma Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
AEON Biopharma Inc Frequently Asked Questions
What is AEON Biopharma Inc(AEON)'s stock price today?
The current price of AEON is $0.54. The 52 week high of AEON is $17.17 and 52 week low is $0.52.
When is next earnings date of AEON Biopharma Inc(AEON)?
The next earnings date of AEON Biopharma Inc(AEON) is 2025-02-13 Est..
Does AEON Biopharma Inc(AEON) pay dividends? If so, how much?
AEON Biopharma Inc(AEON) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers